Mr. Azim Z. Ansari

Assistant Professor

Qualification: M. Pharm., Ph.D. (Pursuing)

Specialization: Pharmaceutical Chemistry

Email ID: azim.ansari@svkm.ac.in

Phone: 7038889437/7875556456

Experience: 05 Years

• 10.06.2019 – Present:
  Institute: Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, MH 5 Position: Assistant Professor
• 09.09.2017 – 07.06.2019
  Institute: DCS’s A.R.A College of Pharmacy, Nagaon, Dhule (M.S) 424005 Position: Assistant Professor

Interest Areas: Organic & Medicinal compound synthesis, Computer Aided Drug Design

Research:

• Publications: International: (05)
  • National: (0)
  • Books: (0)
• Book Chapters: (02)
• Patents: (00)
• Presentations:
  • International: (01)
  • National: (00)
• Completed Government Funded Projects: (00)
  Role (Principal Investigator, etc.) Area of Project Name of Governing Body (Give Complete List)

Industry Projects:

• Completed: (00)
• Ongoing: (00)

Conferences/Workshops/Seminars attended: (30)

Academic Activities:

• Ph.D.: Awarded (00)
• Registered:
• M. Pharm Guided: (00)
• B. Pharm Guided: (20)

Awards:

Professional Membership:

• Registered Pharmacist in the Maharashtra State Pharmacy Council
• Life member of the Indian Pharmaceutical Association
• Life member of the Association of Pharmaceutical Teachers of India

Recent Publications:

• Pawara R, Ahmad I, Nayak D, Wagh S, Wadkar A, Ansari A, Belamkar S, Surana S, Kundu CN, Patil C, Patel H. Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC). Bioorganic Chemistry. 2021 Oct 1;115:105234. (Impact factor:5.275)
• Siddique MU, Ansari A, Sinha BN, Jayaprakash V. Comparative Computational Studies on Selective CytochromeP450 1B1 Inhibitors. International Journal Bioautomation. 2020;24(3):213. (Impact factor:0.352)
• Patel H, Ansari A, Pawara R, Ansari I, Jadhav H, Surana S. Design and synthesis of novel 2, 4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors. Journal of Receptors and Signal Transduction. 2018 Nov 2;38(5-6):393-412. (Impact factor: 2.092)
• Patel H, Pawara R, Ansari A, Surana S. Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance. European journal of medicinal chemistry. 2017 Dec 15;142:32-47. (Impact factor:7.088)
• Patel HM, Pawara R, Ansari A, Noolvi M, Surana S. Design and synthesis of quinazolinones as EGFR inhibitors to overcome EGFR resistance obstacle. Bioorganic & medicinal chemistry. 2017 May 15;25(10):2713-23. (Impact factor:3.641)